Navigation Links
Abide Therapeutics Appoints Dr. Gary O'Neill as Vice President of Biology
Date:10/29/2013

SAN DIEGO, Oct. 29, 2013 /PRNewswire/ -- Abide Therapeutics announces today that Gary O'Neill, Ph.D., has joined Abide Therapeutics as vice president of biology and member of the senior management team. Dr. O'Neill was previously in Boston, where he was responsible for Merck's preclinical drug discovery programs in respiratory, immunology and oncology.

(Logo: http://photos.prnewswire.com/prnh/20130502/LA06084LOGO)

"Dr. O'Neill has more than 20 years of experience advancing drug discovery programs to clinical trials," said Alan Ezekowitz, MBChB, D.Phil., president and CEO of Abide Therapeutics. "His extensive experience as a molecular biologist, in-depth knowledge of multiple disease areas, and proven success in advancing drug candidates from target discovery to clinical trials will drive our research and development programs as we advance a pipeline of novel small molecules targeting the large and therapeutically relevant family of serine hydrolases."

"Abide's ability to selectively and near-universally target the more than 200 members of the serine hydrolase 'superfamily' is a unique platform to extract the therapeutic potential from this enzyme class," said Dr. O'Neill. "I am looking forward to joining the team at Abide as we work to discover and develop novel medicines in many therapeutic areas."

Dr. O'Neill's long-standing career with Merck started in 1990 when he joined as a senior research scientist. His scientific accomplishments lead to leadership positions of increasing responsibility at Merck Frosst Research Laboratories, and by 2006, Dr. O'Neill was executive director and head of biology, where he was responsible for a large research team engaged in the discovery and clinical advancement of innovative sma
'/>"/>

SOURCE Abide Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
11. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Dompe, a leader in R&D for new ... rhNGF (Recombinant Human Nerve Growth Factor) has been designated as ... (FDA). The candidate drug, developed by the ... for the treatment of neurotrophic keratitis, a degenerative corneal disease ... and is currently without a cure. This is the second ...
(Date:7/23/2014)... 2014 Research and Markets ... Medical Kits and Trays - Global Strategic Business ... http://photos.prnewswire.com/prnh/20130307/600769 This ... Kits and Trays in US$ Thousands by the ... Trays, Custom Basin Kits, Custom Ob/Gyn Kits, General ...
(Date:7/23/2014)... 2014  ArmaGen, a privately held biotechnology company ... neurological disorders, announced today that it has entered ... Shire plc to develop AGT-182, an investigational enzyme ... the central nervous system (CNS) and somatic (body-related) ... II, Hunter syndrome is a rare, severe, progressive ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3
(Date:7/23/2014)... 23, 2014 The discounts that some ... products do not include various skin creams or oil ... skin tightening cream discounts inside of its cost saving ... is now available to offer a direct source for ... products available for sale. Although the guide includes pricing, ...
(Date:7/23/2014)... Men and women who are married ... insurance based on national averages. The Quotes Pros company ... to its comprehensive tool this year to help married ... , Providers that are now underwriting plans on a ... one or two clicks. The intelligent platform used to ...
(Date:7/23/2014)... July 23, 2014 The puffiness that ... using non-surgical techniques, according to a new guide published ... serum sold in the U.S. is now available for ... , The complimentary guide that is now published is ... with under eye puffiness. While surgical techniques are available, ...
(Date:7/23/2014)... 2014 Recently, iFitDress.com, a professional company of ... of 2014 vintage party dresses . Aside from that, ... current discount is up to 63% off. , “We are ... These new items are all manufactured by trustworthy and experienced ... until July 30; it is great to provide such a ...
(Date:7/23/2014)... 23, 2014 In preparation for National ... Millennium Treatment Group is providing tips on choosing a ... society ever since man first figured out the process ... has existed since shortly thereafter. Its basis lies in ... then developing a way to combat that problem while ...
Breaking Medicine News(10 mins):Health News:Skin Tightening Cream Discounts Revealed in New Cost Saving Guide at Consumer Portal 2Health News:Cheap Life Insurance Rates for Married Couples Added to Search System at Insurer Portal Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3
... embryos or adult mice to behave like stem cells ... in an immediate early publication of the journal Cell. ... stem cells" (iPS) behaved physically and genetically as stem ... used to treat a host of diseases, such as ...
... a ban on Coke and Pepsi by the Kerala Government, the ... forth a proposal to stop the sale// and production of 11 ... ,Top brass in the companies are very unhappy over these moves, ... company which is not in sync with the reports from ...
... has called for moratoriums on consumer advertising which promotes ... that the products// are safe and that they work. ... group has urged the U.S. Food and Drug Administration ... after a drug or device obtains regulatory approval before ...
... found in a study that instead of dieting, which could ... and thereby a desire// to change it, women who accept ... lowest body mass index (BMI). ,The researchers have ... disorders. Tracy Tylka, assistant professor of psychology and one of ...
... is a rare condition that affects children as well ... named anakinra could alleviate// symptoms and bring down the ... in the August 10 issue of the New England ... Research Program of the National Institute of Arthritis and ...
... a sharp rise in polio cases in the country with ... as against a total of 66 last year.// ... upper house, Friday that the transmission of poliovirus may continue ... target". ,In a written answer he said that ...
Cached Medicine News:Health News:Only A Few Differentiating Factors Between Adult And Stem Cells 2Health News:Drug Advertising needs to be Limited 2Health News:Study Finds Healthier Women Are Those Who Accept The Way They Look 2Health News:NOMID Symptoms Helped By Arthritis Drug 2Health News:NOMID Symptoms Helped By Arthritis Drug 3
... Model 3085 temporary pacemaker is designed to ... for temporary atrial or ventricular or A-V ... where such pacing modes are indicated for ... Model 3085 can be used to measure ...
... a unique left ventricular assist device that helps ... being used in a small group of patients ... of an FDA-approved Feasibility Study. The patient can ... power source for minutes or hours. The Kantrowitz ...
... system provides an ideal solution for ... laboratory, satellite lab and the clinic ... method with wedge-smear technology, the ADVIA ... in a safe enclosed environment. The ...
... T600 treadmill has streamlined design, ... a brushless DC motor and ... unique system that operates on ... in smooth operation, remarkably low ...
Medicine Products: